Terms: = Endocrine gland cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
15 results:
1. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes cancer Cell Proliferation and Migration in Ovarian cancer.
Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
[TBL] [Abstract] [Full Text] [Related]
2. Whole Genome Sequencing Reveals Independent Clonal Origin of Bilateral Testicular Germ Cell Tumors in 2 Patients with Pure Seminoma.
Biles MJ; Haffner MC; Hanratty B; Pierorazio PM
Urology; 2022 Jul; 165():184-186. PubMed ID: 35157907
[TBL] [Abstract] [Full Text] [Related]
3. The correlation between the expression of ATF4 and procalcitonin combined with the detection of
Ma S; Wang H; Li W; Yan Z; Luo X; Lu P
Can J Physiol Pharmacol; 2022 Jan; 100(1):19-25. PubMed ID: 34822305
[TBL] [Abstract] [Full Text] [Related]
4. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
[TBL] [Abstract] [Full Text] [Related]
5. CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652.
Zhao Y; Hu Y; Shen Q; Chen Q; Zhu XJ; Jiang SS; Zhang Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5281-5291. PubMed ID: 32495861
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer.
Ou ZL; Luo Z; Lu YB
World J Gastroenterol; 2019 Dec; 25(46):6728-6742. PubMed ID: 31857775
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer.
Yang XS; Wang GX; Luo L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):616-622. PubMed ID: 29461589
[TBL] [Abstract] [Full Text] [Related]
8. AIB1 regulates the ovarian cancer cell cycle through TUG1.
Li L; Gan ZH; Qin L; Jiao SH; Shi Y
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5610-5617. PubMed ID: 29271993
[TBL] [Abstract] [Full Text] [Related]
9. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract] [Full Text] [Related]
10. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
11. [Melanoma of the anal margin].
Lerondeau B; Granel-Brocard F; Cuny JF; Specty-Ferry J; Bressler L; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2013; 140(6-7):444-7. PubMed ID: 23773742
[TBL] [Abstract] [Full Text] [Related]
12. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
[TBL] [Abstract] [Full Text] [Related]
13. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
14. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
[TBL] [Abstract] [Full Text] [Related]
15. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract] [Full Text] [Related]
